AI in drug discovery: 2025 in review

Pour ceux qui espéraient que l’intelligence artificielle aiderait à fournir des médicaments réellement efficaces, l’espoir perdure. Ici, le Dr Raminderpal Singh revient sur la triste réalité que 2025 a apportée à l’industrie. L’année 2025 restera dans les mémoires comme le moment où la découverte de médicaments contre l’IA est passée de la promesse à la…

Read More

Contracting for AI Acquisition in a Rapid-Adoption Era – IPWatchdog.com

Contracts for acquiring AI in the era of rapid adoption See the speakers Organizations and government agencies are acquiring AI at unprecedented speed, often faster than legal, procurement and governance frameworks can adapt. Standard software contracts are pushed beyond their limits, exposing buyers to unclear ownership of outcomes, weak data rights, opaque model behavior, regulatory…

Read More

Supply chain resilience and AI readiness start with location-based data

For many supply chain organizations, the resilience conversation has shifted from reacting to disruption to understanding exposure. This shift requires companies to dig deeper, beyond tier-one suppliers, beyond transactional data, and into the physical and geographic realities that shape how goods are purchased, moved and stored over time. The question is no longer whether organizations…

Read More

Six Trends That Will Decide Who Wins the Next Decade

Artificial intelligence (AI) is advancing faster than the network that powers it. As Microsoft CEO, Satya Nadella recently warnedthe real limit of AI isn’t the chips… it’s the electricity. Energy has become the main bottleneck in AI, pushing tech giants to create their own energy source and reboot all available energy sources. Whoever gains this…

Read More